Powder: -20°C for 3 years | In solvent: -80°C for 1 year
10058-F4 (c-Myc Inhibitor) is a cell-permeable thiazolidinone that specifically inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression; induces cell-cycle arrest and apoptosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 68.00 | |
25 mg | In stock | $ 109.00 | |
50 mg | In stock | $ 166.00 | |
100 mg | In stock | $ 243.00 | |
500 mg | In stock | $ 597.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 46.00 |
Description | 10058-F4 (c-Myc Inhibitor) is a cell-permeable thiazolidinone that specifically inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression; induces cell-cycle arrest and apoptosis. |
Cell Research | Cells, plated in 96-well plates (105/mL for cell lines and 5 × 105/mL for primary leukemic cells), are treated in triplicate with indicated concentrations of 10058-F4. At various time points, 20 μL 5 mg/mL MTT is added to each well. After incubation at 37°C for 3 hours, the MTT medium is removed and 100 μL DMSO lysis buffer is added. The number of viable cells is assessed by the percentage of absorbance of treated cells relative to that of solvent controls, using 570-nm wavelength on a spectrophotometer.(Only for Reference) |
Synonyms | c-Myc Inhibitor |
Molecular Weight | 249.35 |
Formula | C12H11NOS2 |
CAS No. | 403811-55-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 24.9 mg/mL (100 mM)
Ethanol: 5 mg/mL (20 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
10058-F4 403811-55-2 Autophagy Cell Cycle/Checkpoint c-Myc Myc 10058F4 c-Myc Inhibitor inhibit 10058-F-4 Inhibitor 10058 F4 inhibitor